Enveda reports positive early safety data for ENV-308, an experimental oral drug inspired by exercise-induced molecule Lac-Phe, as it advances toward larger studies to assess its potential in weight regain prevention after GLP-1 therapy. Enveda has reported encouraging first human…
Despite a new Medicare pilot programme aimed at making GLP-1 weight-loss medications more affordable, restrictions based on health conditions leave out many patients, including a retired professor with severe obesity and health issues. Jeff La Marca thought he had found…
New developments in glucose screening methods and timing are transforming how pregnant women in the US are tested for gestational diabetes, highlighting a shift towards earlier and more accurate detection to improve maternal and neonatal outcomes. For most pregnant women…
While clinical trials show significant weight regain after stopping GLP-1 medicines like semaglutide and tirzepatide, recent real-world research highlights the potential for sustained progress through follow-up care and lifestyle modifications, underscoring the importance of personalised long-term approaches. Research on GLP-1…
A six-month trial suggests that daily consumption of a large avocado can slightly reduce the overall glycaemic load of the diet in adults with abdominal obesity, potentially supporting better blood sugar management. A six-month randomised trial in adults with larger…
Emerging research suggests that prolonged stress during the menopause transition can elevate cortisol levels, strain the liver, and increase risk of metabolic diseases such as fatty liver, highlighting the need for stress management in women’s health. Stress may do more…
New insights into neonatal diabetes reveal that remission is often temporary, with about half of affected children experiencing a relapse during adolescence or early adulthood, highlighting the importance of ongoing monitoring and genetic testing. Neonatal diabetes is a rare condition…
Two European geriatricians argue that insulin resistance in older adults is more about declining physiological resilience in muscle, fat tissue, and the brain than just excess body fat, highlighting the importance of functional health over blood sugar metrics. Two European…
The US Food and Drug Administration has documented over 1,700 adverse-event reports related to illegal compounded versions of semaglutide and tirzepatide, amid rising regulatory scrutiny and ongoing market disputes in the lucrative obesity drug sector. The US Food and Drug…
A family physician explores how different values shape perceptions of success in medicine, advocating for a broader understanding that aligns with what patients truly value. Christine Marie Deeths, a family physician who teaches palliative medicine, turns a personal argument into…
